Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 14:17:04 UTC |
---|
Update Date | 2021-09-26 23:09:07 UTC |
---|
HMDB ID | HMDB0254828 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Mofebutazone |
---|
Description | Mofebutazone, also known as monazone or 2 FDBP, belongs to the class of organic compounds known as benzene and substituted derivatives. These are aromatic compounds containing one monocyclic ring system consisting of benzene. Based on a literature review a significant number of articles have been published on Mofebutazone. This compound has been identified in human blood as reported by (PMID: 31557052 ). Mofebutazone is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Mofebutazone is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CCCCC1C(O)=NN(C1=O)C1=CC=CC=C1 InChI=1S/C13H16N2O2/c1-2-3-9-11-12(16)14-15(13(11)17)10-7-5-4-6-8-10/h4-8,11H,2-3,9H2,1H3,(H,14,16) |
---|
Synonyms | Value | Source |
---|
1-Phenyl-4-butyl-3,5-pyrazolidinedione | ChEBI | 2 FDBP | ChEBI | 2-Phenyl-3,5-dihydroxy-4-butylpyrazolidine | ChEBI | 4-Butyl-1-phenyl-3,5-dioxopyrazolidine | ChEBI | 4-Butyl-1-phenyl-3,5-pyrazolidinedione | ChEBI | Mofebutazona | ChEBI | Mofebutazonum | ChEBI | Monazone | ChEBI | Monophenylbutazone | ChEBI | Mophebutazone | ChEBI | Nabumetone | ChEBI | Mofebutazone | MeSH | Mofesal N | MeSH | Monophenylbutazone, sodium salt | MeSH | 1-Phenyl-4-N-butyl-3,5-dioxopyrazolidine | MeSH |
|
---|
Chemical Formula | C13H16N2O2 |
---|
Average Molecular Weight | 232.283 |
---|
Monoisotopic Molecular Weight | 232.121177763 |
---|
IUPAC Name | 4-butyl-3-hydroxy-1-phenyl-4,5-dihydro-1H-pyrazol-5-one |
---|
Traditional Name | mozol |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCCCC1C(O)=NN(C1=O)C1=CC=CC=C1 |
---|
InChI Identifier | InChI=1S/C13H16N2O2/c1-2-3-9-11-12(16)14-15(13(11)17)10-7-5-4-6-8-10/h4-8,11H,2-3,9H2,1H3,(H,14,16) |
---|
InChI Key | REOJLIXKJWXUGB-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as benzene and substituted derivatives. These are aromatic compounds containing one monocyclic ring system consisting of benzene. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Not Available |
---|
Direct Parent | Benzene and substituted derivatives |
---|
Alternative Parents | |
---|
Substituents | - Monocyclic benzene moiety
- Pyrazolidinone
- 1,3-dicarbonyl compound
- Pyrazolidine
- Carboxylic acid hydrazide
- Azacycle
- Organoheterocyclic compound
- Carboxylic acid derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Organooxygen compound
- Organonitrogen compound
- Carbonyl group
- Organic nitrogen compound
- Hydrocarbon derivative
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Mofebutazone GC-MS (Non-derivatized) - 70eV, Positive | splash10-0kbf-9550000000-ac601c69eb5b7fe709f7 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Mofebutazone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Mofebutazone GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Mofebutazone GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mofebutazone 10V, Positive-QTOF | splash10-001i-1290000000-87f846d1fede9337231a | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mofebutazone 20V, Positive-QTOF | splash10-030u-9840000000-30fd58f270c54b5ded3c | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mofebutazone 40V, Positive-QTOF | splash10-00kf-9100000000-f51ae44c4883c3bd565e | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mofebutazone 10V, Negative-QTOF | splash10-001i-0190000000-8d1836f3268ad95190b7 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mofebutazone 20V, Negative-QTOF | splash10-01ox-9650000000-765dd1df8cb22f0cb6ff | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mofebutazone 40V, Negative-QTOF | splash10-00kf-9400000000-ec885019f1617d304406 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mofebutazone 10V, Positive-QTOF | splash10-001i-0090000000-81d7d770f98dde50e824 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mofebutazone 20V, Positive-QTOF | splash10-001l-2980000000-4277ecf30deadba3cfc3 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mofebutazone 40V, Positive-QTOF | splash10-00ou-9100000000-11a985e2e79d8cd23b51 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mofebutazone 10V, Negative-QTOF | splash10-001i-0090000000-662f7b5a22c8f359e512 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mofebutazone 20V, Negative-QTOF | splash10-001i-2490000000-d741bf936a3392a5d68d | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mofebutazone 40V, Negative-QTOF | splash10-0006-9410000000-e68f7067e09669cdb019 | 2021-10-12 | Wishart Lab | View Spectrum |
|
---|